Evidence map›Paper›PMID 34306446›Full record

ArticleAmerican journal of translational research2021

An analysis of the 28-day mortality risk factors in acute respiratory distress syndrome patients and the establishment of prediction models.

Hui Chen, Qiong Liu, Lifeng Wang

Abstract read
In one paragraph

Article in American journal of translational research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hui ChenDepartment of Emergency, Loudi Central Hospital, Loudi Hu'nan Province, China.
Qiong LiuDepartment of Cardiology, Loudi Central Hospital, Loudi Hu'nan Province, China.
Lifeng WangDepartment of Emergency, Loudi Central Hospital, Loudi Hu'nan Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo explore the risk factors and prediction models of 28-day mortality in acute respiratory distress syndrome (ARDS) patients.

methodsA total of 215 ARDS patients treated in our hospital were enrolled in this prospective observational study, including 70 patients who died within 28 days and were placed in the death group, and the remaining 145 patients who survived and were placed in the survival group. The laboratory examination indexes and critical scoring system scores were compared between the two groups. A Cox regression analysis was used to analyze the factors associated with 28-day mortality, and a receiver operating characteristic (ROC) curve was used to analyze the performance of the prediction models.

resultsThe ROC curve analysis showed that the erythrocyte distribution width (RDW), the neutrophil to lymphocyte ratio (NLR), the procalcitonin to albumin ratio (PAR), and the Murray lung injury score (MLIS) were effective at diagnosing the 28-day mortality, each with an area under the curve (AUC) of >0.5 (P<0.001). A multivariate Cox analysis showed that the RDW, NLR, PAR, and MLIS were independent predictors of 28-day mortality. The results of the multi-index joint prediction showed that the AUC of RDW+NLR+PAR+MLIS was 0.945 (95% CI: 0.910-0.979), and the sensitivity was as high as 94.25%.

conclusionNLR, PAR, RDW, and MLIS are independent predictors of 28-day mortality, and their combined prediction can significantly improve the predictive ability of the 28-day mortality in ARDS patients.

Indexed as

28-day mortalityAcute respiratory distress syndromeneutrophil to lymphocyte ratioprocalcitonin to albumin ratiorisk factors

Identifiers

PMID34306446
PMCPMC8290800

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.